01 / EXECUTIVE SUMMARY
What the evidence
establishes.
OLAF traced and analysed a cross-border route distributing more than 200,000 counterfeit condoms bearing the name and logo of a well-known brand.
01 / EXECUTIVE SUMMARY
OLAF traced and analysed a cross-border route distributing more than 200,000 counterfeit condoms bearing the name and logo of a well-known brand.
02 / WHAT HAPPENED
OLAF traced and analysed a cross-border route distributing more than 200,000 counterfeit condoms bearing the name and logo of a well-known brand.
The chain distinguishes what appeared valid, what was physically true, which authority followed and what consequence the source documents.
Branding, packaging and sales presentation claimed the products were genuine protective products from an established manufacturer.
OLAF identified untested, uncontrolled counterfeit products from a common source in China.
The products were sold in Europe and accepted for use as health-protection devices.
OLAF warned of sexually transmitted infection exposure and placed original-market value above EUR 200,000; no individual case count was reported.
Unit- or batch-level verification connecting the physical product to manufacturer and quality evidence.
ECR separates a documented monetary floor from a modeled social and economic consequence envelope. It is not an accounting loss figure.
The range combines documented facts with calibrated consequence and response-cost assumptions; it is not an accounting loss figure.
Volumes, route and stated hazards are OLAF facts. 4SI supplies the missing-boundary analysis.
Brand identity created an expectation of tested physical protection that the actual objects could not substantiate.
4SI does not claim to have independently verified the underlying event. Scores, boundary analysis and economic ranges interpret published evidence; they are not probabilities, compliance findings, valuations or loss forecasts.
Related cases are editorially connected by domain, authority pattern or missing physical trust boundary.